Cargando…
Dexamethasone/favipiravir/metoclopramide: Sinus bradycardia, deranged liver enzymes and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137428/ http://dx.doi.org/10.1007/s40278-021-96169-z |
Ejemplares similares
-
Azithromycin/favipiravir: Sinus bradycardia following interaction and off label use: case report
Publicado: (2022) -
Dexamethasone/remdesivir: Sinus bradycardia and off label use in COVID-19 and :case report
Publicado: (2021) -
SEVERE SINUS BRADYCARDIA INDUCED BY FAVIPIRAVIR
por: Habib, Mhd Baraa, et al.
Publicado: (2021) -
Dexamethasone/metoprolol-succinate/remdesivir: Sinus bradycardia following drug interaction and off label use: case report
Publicado: (2022) -
Dexamethasone/remdesivir: Derangement of liver function tests, pneumocystis pneumonia and off-label use: case report
Publicado: (2022)